Vtama

(tapinarof)
Vtama 1 % Topical Cream
NO BOXED WARNING

Dosage & administration

Apply a thin layer of VTAMA cream to affected areas once daily.

VTAMA cream is not for oral, ophthalmic, or intravaginal use.

drug label

Vtama prescribing information

prior authorization

Vtama prior authorization resources

Most recent Vtama prior authorization forms

View By Payer
Verified: Feb 07, 2024Kaiser Foundation Health Plan - Chronic High-Dose Opioid Therapy Prior Authorization Form Washington
Verified: Feb 01, 2024Highmark BCBS Northeastern NY - Medicare Prescription Drug Medication Request Form
Verified: Feb 01, 2024Highmark BCBS Northeastern NY - Short Acting Opioid Prior Authorization Form
Verified: Feb 01, 2024Highmark BCBS Western NY - Specialty Drug Prior Authorization Form
Verified: Feb 01, 2024Highmark BCBS Western NY - Non-Formulary Drug Coverage Prior Authorization Form

Most recent state uniform prior authorization forms

Verified: Feb 27, 2024Arizona - Uniform Prior Authorization Form
Verified: Feb 27, 2024Colorado - Uniform Prior Authorization Form
Verified: Feb 27, 2024Hawaii - Uniform Prior Authorization Form
Verified: Feb 27, 2024Illinois - Uniform Prior Authorization Form
Verified: Feb 27, 2024Indiana - Uniform Prior Authorization Form
Verified: Feb 27, 2024Louisiana - Uniform Prior Authorization Form
Verified: Feb 27, 2024Michigan - Uniform Prior Authorization Form
Verified: Feb 27, 2024Minnesota - Uniform Prior Authorization Form
Verified: Feb 27, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Feb 27, 2024New Mexico - Uniform Prior Authorization Form
Verified: Feb 27, 2024Oregon - Uniform Prior Authorization Form
Verified: Feb 27, 2024Texas - Uniform Prior Authorization Form
Coverage Authorization Request
Appeals Request Letter
Formulary Exception Letter
Learn More

Financial Assistance

Financial Assistance Programs

Vtama retails for $1,468 per dose without insurance or financial assistance.Depending on your patient's insurance situation and other eligibility criteria, they may be able to get Vtama for significantly less. Review the program information below to determine what program can offer your patient the most benefits.
CoPay Card Program$0 Co Pay
Available for
commercial
Program Details
  • $1468 for Tube
Forms
Enroll in Patient Savings Program
Get Started with Vtama
Foundation ProgramFirst dose for $0
Available for
medicare
uninsured
Eligibility requirements
  • Uninsured
  • Medicare
  • Medicaid
  • Household annual adjusted gross income <= 250% FPL.
Forms
Dermavant Foundation Program

PubMed™ | Vtama

Vtama PubMed™ News

patient education

Vtama patient education

Getting started on Vtama

Instructions For Use: Adult Plaque Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Doctor Discussion Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Vtama
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Vtama FAQs

1. Is VTAMA cream safe to use during pregnancy?The available data on VTAMA cream use in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. In animal reproduction studies, there were no significant adverse effects at certain doses in pregnant rats and rabbits. However, the estimated background risk of major birth defects and miscarriage for pregnant women using VTAMA cream is unknown.
2. What is the background risk of major birth defects and miscarriage during pregnancy?All pregnancies have a background risk of major birth defects, loss, and other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively.
3. What does the animal data reveal about VTAMA cream use during pregnancy?In animal studies, VTAMA cream did not result in significant adverse effects at certain doses in pregnant rats and rabbits, except for an increased incidence of skeletal variations in rabbits at a high dose. However, no embryofetal lethality or major fetal malformations were observed at recommended human doses.
4. Can tapinarof be detected in human milk when using VTAMA cream during lactation?No data are available regarding the presence of tapinarof in human milk when using VTAMA cream. However, tapinarof was detected in rat offspring, suggesting that it may be transferred into the milk of lactating rats. When a drug is present in animal milk, it is likely that it will be present in human milk, so the potential effects on breastfed infants should be considered.
5. Is VTAMA cream safe for pediatric use in psoriasis patients under 18 years of age?Safety and efficacy of VTAMA cream have not been established in pediatric subjects with psoriasis under 18 years of age. Therefore, its use in this age group is not recommended.
6. What are the findings from the juvenile animal toxicity study for VTAMA cream?In a juvenile animal toxicity study, VTAMA cream was administered to juvenile rats at various doses. Renal pelvic dilatation was observed at higher doses, but no adverse effects in juvenile animals were noted at lower doses.
7. Is VTAMA cream safe for use in elderly individuals?In clinical trials, there were no overall differences in efficacy, safety, or tolerability observed between elderly subjects (65 years of age and older) and younger adult subjects when using VTAMA cream.
FAQ Data Source